Technical Analysis for BAX - Baxter International Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Flat |
Historical BAX trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.25% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.25% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 1.35% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 1.35% | |
Down 3 Days in a Row | Weakness | 1.35% | |
Cup with Handle | Other | 0.25% | |
NR7 | Range Contraction | 0.25% | |
Inside Day | Range Contraction | 0.25% | |
Overbought Stochastic | Strength | -0.18% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.96% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
10 DMA Resistance | 34 minutes ago |
10 DMA Support | about 2 hours ago |
Non-ADX 1,2,3,4 Pullback Entry | about 2 hours ago |
1,2,3, Pullback Entry | about 2 hours ago |
Rose Above Previous Day's High | about 2 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 04/28/2021
Baxter International Inc. Description
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Infectious Diseases Disorders Dialysis Kidney Disease Medical Products Membrane Technology Medical Research Immune Disorders Nutrition Products Hemodialysis Renal Disease Hemophilia Syringe Burns Deerfield End Stage Renal Disease Infusion Pump Stage Renal Disease Antitrypsin Deficiency Kidney Nephrology Renal Dialysis Hemophilia A Drug Wholesalers Kidney Dialysis Specialty Pharmacy Kidney Failure Alpha 1 Antitrypsin Compounding Peritoneal Dialysis Biosurgery Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 95.19 |
52 Week Low | 74.79 |
Average Volume | 2,576,811 |
200-Day Moving Average | 81.14 |
50-Day Moving Average | 79.68 |
20-Day Moving Average | 82.69 |
10-Day Moving Average | 85.00 |
Average True Range | 1.36 |
ADX | 34.73 |
+DI | 28.67 |
-DI | 13.95 |
Chandelier Exit (Long, 3 ATRs ) | 82.46 |
Chandelier Exit (Short, 3 ATRs ) | 81.05 |
Upper Bollinger Band | 87.93 |
Lower Bollinger Band | 77.45 |
Percent B (%b) | 0.71 |
BandWidth | 12.68 |
MACD Line | 1.62 |
MACD Signal Line | 1.59 |
MACD Histogram | 0.0306 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 86.53 | ||||
Resistance 3 (R3) | 86.35 | 85.64 | 86.26 | ||
Resistance 2 (R2) | 85.64 | 85.23 | 85.73 | 86.17 | |
Resistance 1 (R1) | 85.28 | 84.98 | 85.46 | 85.46 | 86.08 |
Pivot Point | 84.57 | 84.57 | 84.66 | 84.66 | 84.57 |
Support 1 (S1) | 84.21 | 84.16 | 84.39 | 84.39 | 83.76 |
Support 2 (S2) | 83.50 | 83.91 | 83.59 | 83.67 | |
Support 3 (S3) | 83.14 | 83.50 | 83.58 | ||
Support 4 (S4) | 83.32 |